We are live on
!
Find out more
GENB
Generate Biomedicines
GENB
GENB
57 hedge funds and large institutions have $1.16B invested in Generate Biomedicines in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holding in Top 10
4
Calls
$157K
Puts
–
Top Buyers
| 1 | +$765M | |
| 2 | +$51.5M | |
| 3 | +$48.9M | |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
+$43.9M |
| 5 |
JP Morgan Chase
New York
|
+$36M |
Top Sellers
No sellers this quarter
